Literature DB >> 16370569

Ghrelin and the metabolic balance.

O Ukkola1.   

Abstract

Several studies have provided evidence that ghrelin is involved in the regulation of metabolic balance. Recent data provide evidence that when studying the effects of ghrelin on energy balance, differential influences of the acylated and non-acylated forms of the peptide must be considered. Although the correlation between the two forms is good, they may be different hormones with opposite actions with non-acylated ghrelin being able to antagonize some of the effects of the acylated form. Future studies will reveal which of the two forms of ghrelin, the acylated or non-acylated forms, dominates and determines the net influence on energy balance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16370569     DOI: 10.1007/bf03347580

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

1.  Circulating ghrelin concentrations are reduced in healthy offspring of Type 2 diabetic subjects, and are increased in women independent of a family history of Type 2 diabetes.

Authors:  T Østergård; T K Hansen; B Nyholm; C H Gravholt; C B Djurhuus; H Hosoda; K Kangawa; O Schmitz
Journal:  Diabetologia       Date:  2003-01       Impact factor: 10.122

2.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

4.  Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.

Authors:  Tomomi Shiiya; Masamitsu Nakazato; Masanari Mizuta; Yukari Date; Muhtashan S Mondal; Muneki Tanaka; Shin-Ichi Nozoe; Hiroshi Hosoda; Kenji Kangawa; Shigeru Matsukura
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

Review 5.  Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor.

Authors:  E Ghigo; F Broglio; E Arvat; M Maccario; M Papotti; G Muccioli
Journal:  Clin Endocrinol (Oxf)       Date:  2005-01       Impact factor: 3.478

6.  Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus.

Authors:  Akira Katsuki; Hideki Urakawa; Esteban C Gabazza; Shuichi Murashima; Kaname Nakatani; Kenji Togashi; Yutaka Yano; Yukihiko Adachi; Yasuhiro Sumida
Journal:  Eur J Endocrinol       Date:  2004-11       Impact factor: 6.664

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.

Authors:  Seppo M Pöykkö; Eija Kellokoski; Sohvi Hörkkö; Heikki Kauma; Y Antero Kesäniemi; Olavi Ukkola
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

9.  Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle.

Authors:  Rocco Barazzoni; Alessandra Bosutti; Marco Stebel; Maria Rosa Cattin; Elena Roder; Luca Visintin; Luigi Cattin; Gianni Biolo; Michela Zanetti; Gianfranco Guarnieri
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-24       Impact factor: 4.310

10.  Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose.

Authors:  Johannes Erdmann; Robert Töpsch; Florian Lippl; Philipp Gussmann; Volker Schusdziarra
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

View more
  3 in total

1.  Interferon-γ inhibits ghrelin expression and secretion via a somatostatin-mediated mechanism.

Authors:  Jesper A B Strickertsson; Kristina B V Døssing; Anna J M Aabakke; Hans-Olof Nilsson; Thomas V O Hansen; Ulrich Knigge; Andreas Kjær; Torkel Wadström; Lennart Friis-Hansen
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

Review 2.  Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population.

Authors:  Krithika Srikanthan; Andrew Feyh; Haresh Visweshwar; Joseph I Shapiro; Komal Sodhi
Journal:  Int J Med Sci       Date:  2016-01-01       Impact factor: 3.738

Review 3.  Leptin and Associated Mediators of Immunometabolic Signaling: Novel Molecular Outcome Measures for Neurostimulation to Treat Chronic Pain.

Authors:  Thomas M Kinfe; Michael Buchfelder; Shafqat R Chaudhry; Krishnan V Chakravarthy; Timothy R Deer; Marc Russo; Peter Georgius; Rene Hurlemann; Muhammad Rasheed; Sajjad Muhammad; Thomas L Yearwood
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.